WASHINGTON — RetireSafe, a Washington-based advocacy group with ties to the drug industry, appears to be behind a deluge of comments on HHS’ controversial proposal to end the current system of rebates used to negotiate the price of drugs.
Roughly 18,000 comments have been submitted about the proposal, a number that far exceeds the normal submission rate for recent Trump administration drug pricing proposals.
More than 5,000 of those comments were made public Wednesday, and nearly all of the available comments reflect the same wording in support of the proposal. That wording matches a RetireSafe-sponsored form letter available at the website SubmitForChange.org.
About the Author Reprints
